Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Renovacor Inc (NY: RCOR ) N/A UNCHANGED Last Price Updated: 8:00 PM EST, Nov 30, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Renovacor Inc Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress October 10, 2022 From Renovacor, Inc. Via Business Wire Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference September 26, 2022 From Renovacor, Inc. Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EVOP, STOR, RCKT, RCOR September 22, 2022 Via ACCESSWIRE RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders September 20, 2022 From Halper Sadeh LLC Via Business Wire Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy September 20, 2022 From Rocket Pharmaceuticals, Inc. and Renovacor, Inc. Via Business Wire Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update August 08, 2022 From Renovacor, Inc. Via Business Wire Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy July 12, 2022 From Renovacor, Inc. Via Business Wire Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research June 01, 2022 From Renovacor, Inc. Via Business Wire Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update May 12, 2022 From Renovacor, Inc. Via Business Wire Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer March 28, 2022 From Renovacor, Inc. Via Business Wire Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update March 24, 2022 From Renovacor, Inc. Via Business Wire Renovacor to Participate in a Panel Presentation at the 11th Annual LifeSci Partners Corporate Access Event January 03, 2022 From Renovacor, Inc. Via Business Wire Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update November 15, 2021 From Renovacor, Inc. Via Business Wire Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations October 04, 2021 From Renovacor, Inc. Via Business Wire Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference September 28, 2021 From Renovacor, Inc. Via Business Wire Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science September 22, 2021 From Renovacor, Inc. Via Business Wire Renovacor to Present at the 2021 Virtual Wells Fargo Healthcare Conference September 07, 2021 From Renovacor, Inc. Via Business Wire Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange September 02, 2021 From Renovacor, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.